Competitive substrate inhibition in the histochemistry of cholinesterase activity in Alzheimer's disease

Christoph R. Schätz*, Changiz Geula, Marsel Mesulam

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

23 Scopus citations

Abstract

We used acetylcholine and butyrylcholine to competitively inhibit the cleavage of acetylthiocholine or butyrylthiocholine in plaques and tangles of Alzheimer's disease. Butyrylcholine was much more effective than acetylcholine in reducing the histochemical reaction for acetylcholinesterase not only in neuronal fibers, but also in plaques and tangles. This is in keeping with biochemical data on acetylcholinesterase and supports the existence of true acetylcholinesterase activity within plaques and tangles. However, 2-4 times higher acetylcholine and buturylcholine concentrations were necessary to inhibit the plaque and tangle bound enzyme. Together with the previously reported different pH optima, this suggests that the plaque- and tangle-bound acetylcholinesterase may represent an altered form of this enzyme.

Original languageEnglish (US)
Pages (from-to)56-61
Number of pages6
JournalNeuroscience Letters
Volume117
Issue number1-2
DOIs
StatePublished - Sep 4 1990

Funding

We would like to thank Kristin Loud and Annmarie Dineen for expert technical assistance. We are grateful to Drs. Bruce Price and James Morris for providing brain tissue. This work was partly supported by NRSA award (AG 05455), an Alzheimer's Disease Research Center Grant (AG 05134), Javits Neuroscience Investigator Award (NS 20285) and the Alzheimer's Disease and Related Disorders Association; Ch.R.S. holds a grant from the Deutsche Forschungsgemeinschaft (DFG).

Keywords

  • Alzheimer's disease
  • Cholinesterase histochemistry
  • Competitive substrate inhibition
  • Plaque
  • Tangle

ASJC Scopus subject areas

  • General Neuroscience

Fingerprint

Dive into the research topics of 'Competitive substrate inhibition in the histochemistry of cholinesterase activity in Alzheimer's disease'. Together they form a unique fingerprint.

Cite this